Clinical Trial Update: Tacrolimus Adjustment by NFAT-related Gene Expression in Lung Allograft Recipients.

View source ↗

Summary

A completed clinical trial update on adjusting tacrolimus dosing by NFAT-related gene expression in lung transplant recipients, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University of California, San Francisco | Conditions: Transplantation, Lung | Status: COMPLETED | Results posted: 2019-12-03